News - Cook Medical
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that Dr. Leslie Hudson, AVI's President and CEO, will present an update on the continuing transition of AVI from an antisense pioneer into a leading discoverer and developer of RNA-based drugs.
Cook Medical has received approval from the FDA to market its improved Zenith abdominal aortic aneurysm iliac flex legs and Z-Trak introduction system, made for use with the Zenith flex AAA endovascular graft.
Further innovating the field of advanced aortic disease repair technologies, Cook Medical today announced approval from the U.S.
Cook Medical, one of the world's largest private medical device companies, announced today a major step forward in the treatment of recto-vaginal fistulas, abnormal tracts that form between a women's rectum and vagina.
